Details of the Drug-Related molecule(s) Interaction Atlas

CCG-208408 Drug Info

Narirutin; Naringenin 7-rutinoside; Naringenin-7-O-rutinoside; (S)-7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-ss-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; AK554011; CCG-208408; CHEMBL3185240; NCGC00163600-01

Cross-matching ID

PubChem CID

85704

CAS Number

CAS 14259-46-2

TTD Drug ID

DMCFEUG

INTEDE Drug ID

DR2439

General Information of Drug (ID: DMCFEUG)

Molecule-Related Drug Atlas

Molecule Type:

DME

Drug Status:

Preclinical Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Metabolized By Beta-glucosidase (bglA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
HY-N0040	DM349AM	N. A.	N. A.	Preclinical	[2]
Ginsenoside Rb1	DMF70AB	N. A.	N. A.	Investigative	[2]
Ginsenoside Rc	DMES9Q2	N. A.	N. A.	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug-Metabolizing Enzyme (DME)

DME Name	DME ID	UniProt ID	MOA	REF
Beta-glucosidase (bglA)^{Main DME}	DEUQTKA	A0A249DCH3_LACRH	Substrate	[1]

------------------------------------------------------------------------------------

References

1	Catabolism of citrus flavanones by the probiotics Bifidobacterium longum and Lactobacillus rhamnosus. Eur J Nutr. 2018 Feb;57(1):231-242.
2	Fermentation of protopanaxadiol type ginsenosides (PD) with probiotic Bifidobacterium lactis and Lactobacillus rhamnosus. Appl Microbiol Biotechnol. 2017 Jul;101(13):5427-5437.